• Thoracic kyphosis |
• Height loss (>4 cm) |
• Type 2 diabetes |
• Falls |
• Inflammatory disease: ankylosing spondylitis, other inflammatory arthritides, connective tissue diseases |
• Endocrine disease: hyperthyroidism, hyperparathyroidism, Cushing’s disease |
• Haematological disorders/malignancy |
• Muscle disease: myositis, myopathies and dystrophies |
• Asthma, chronic obstructive pulmonary disease |
• HIV infection |
• Neurological/ psychiatric disease, e.g. Parkinson’s disease, multiple sclerosis, stroke, depression, dementia |
• Nutritional deficiencies: calcium, vitamin D, magnesium, protein (note that vitamin D deficiency may contribute to fracture risk through undermineralisation of bone (osteomalacia) rather than osteoporosis) |
• Medications |
• Some immunosuppressants (calmodulin/calcineurine phosphatase inhibitors) |
• (Excess) thyroid hormone treatment (levothyroxine and/or liothyronine). Patients with thyroid cancer with suppressed TSH are at particular risk |
• Drugs affecting gonadal hormone production (aromatase inhibitors, androgen-deprivation therapy, medroxyprogesterone acetate, gonadotrophin hormone releasing agonists) |
• Some antidiabetic drugs |
• Some antipsychotics |
• Some anticonvulsants |
• Proton pump inhibitors |